Back to Authors

Ku, Jennifer H

https://orcid.org/0000-0001-9469-5875

A5066357944 | I126345244

Mayo Clinic

Portland State University

Citations 4

Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines

Clinical Infectious Diseases | September 22, 2022 | Volume: 76 | Issue: 2 | Pages: 338-341

10.1093/cid/ciac788 | PMID 36134755

Abstract Among 1038 participants with pulmonary Mycobacterium avium complex and 120 with Mycobacterium abscessus enrolled in the US Bronchiectasis and NTM Research Registry, less than half received antibiotic therapy in the 24 months before registry enrollment, of which less than half were guideline based. Adverse effects occurred in 21% of therapy recipients, of whom 33% discontinued therapy.
Limited Validity of Diagnosis Code–based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data

Annals of the American Thoracic Society | January 21, 2021 | Volume: 18 | Issue: 7 | Pages: 1246-1249

10.1513/annalsats.202007-767rl | PMID 33476243

Pulmonary Nontuberculous Mycobacterial Infection in Patients in the U.S. Bronchiectasis Research Registry: Use of Antibiotic Therapy and Adverse Events

B106. BREAKTHROUGHS IN NTM DIAGNOSIS AND TREATMENT | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A4358-A4358

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4358

The Validity of Claims-Based Codes to Identify Pseudomonas Infection in Patients with Bronchiectasis in Medicare Data

C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5697-A5697

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5697